HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

epratuzumab

Also Known As:
AMG-412; HLL2; IMMU-HLL2; LymphoCide; hLL2 agent
Networked: 89 relevant articles (14 outcomes, 37 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Goldenberg, David M: 30 articles (01/2018 - 01/2003)
2. Wegener, William A: 14 articles (01/2018 - 08/2003)
3. Leonard, John P: 10 articles (11/2013 - 02/2002)
4. Dörner, Thomas: 7 articles (01/2018 - 01/2006)
5. Gordon, Caroline: 6 articles (01/2018 - 07/2013)
6. Coleman, Morton: 6 articles (11/2008 - 08/2003)
7. Shock, Anthony: 5 articles (01/2018 - 10/2012)
8. Cesano, Alessandra: 5 articles (02/2007 - 04/2003)
9. Wallace, Daniel J: 4 articles (01/2017 - 07/2013)
10. Chang, Chien-Hsing: 4 articles (01/2015 - 10/2010)

Related Diseases

1. Systemic Lupus Erythematosus (Libman-Sacks Disease)
2. Non-Hodgkin Lymphoma (Lymphosarcoma)
3. Autoimmune Diseases (Autoimmune Disease)
4. Neoplasms (Cancer)
5. Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)

Related Drugs and Biologics

1. Rituximab (Mabthera)
2. Monoclonal Antibodies
3. Immunoglobulin G (IgG)
4. veltuzumab
5. belimumab
6. Irinotecan (Camptosar)
7. Antibodies
8. Vincristine (Oncovin)
9. Alemtuzumab (Campath)
10. Inotuzumab Ozogamicin

Related Therapies and Procedures

1. Therapeutics
2. Drug Therapy (Chemotherapy)
3. Radioimmunotherapy
4. Immunotherapy
5. Stents